Hemophilia Clinical Trials
Hemophilia clinical trials are research studies evaluating new treatments, therapies, and approaches for hemophilia. Corterve aggregates actively recruiting Hemophilia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility criteria. Participation is always voluntary. This page provides general information and is not medical advice; discuss any trial with your healthcare provider before taking part.
Recruiting Hemophilia studies
- Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia BNCT07080905PHASE3CSL BehringHemophilia BOrange, California
- A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia BNCT06379789PHASE1, PHASE2Regeneron PharmaceuticalsHemophilia BPhoenix, Arizona
- Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B RespectivelyNCT05568719PHASE3PfizerHemophilia ARancho Cordova, California
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia ANCT05987449PHASE1, PHASE2Hoffmann-La RocheHemophilia ASacramento, California
- A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia ANCT07416604PHASE3Hoffmann-La RocheHemophilia AOrange, California
- A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)NCT07582276Arkansas Children's Hospital Research InstituteHemophilia aLittle Rock, Arkansas
- TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII TherapiesNCT07692217University of Texas Southwestern Medical CenterHemophilia ADallas, Texas
- Treatment of Hemophilia A Patients With FVIII InhibitorsNCT04023019Emory UniversityHemophilia AAtlanta, Georgia
- A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia ANCT07416526PHASE3Hoffmann-La RocheHemophilia AAurora, Colorado
- A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia BNCT05611801PHASE3PfizerHemophilia ASalt Lake City, Utah
- A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With EmicizumabNCT06145373PHASE4SanofiHemophilia ALos Angeles, California
- A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia ANCT07226206PHASE1, PHASE2Hoffmann-La RocheHemophilia AOrange, California
Hemophilia trials by state
Hemophilia trials by metro
Frequently asked questions
- How do I find recruiting Hemophilia clinical trials?
- Browse the actively recruiting Hemophilia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Hemophilia clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Hemophilia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.